NCT04464577View on ClinicalTrials.gov

A Study to Evaluate the Effect of Fluconazole, Bupropion, or Itraconazole on the Drug Levels and Safety of BMS-986235

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

April 1, 2021

Primary Completion Date

June 7, 2021

Study Completion Date

June 8, 2021

Conditions
Healthy Participants
Interventions
DRUG

Fluconazole

Specified Dose on Specified Days

DRUG

Bupropion

Specified Dose on Specified Days

DRUG

Itraconazole

Specified Dose on Specified Days

DRUG

BMS-986235

Specified Dose on Specified Days

Trial Locations (2)

66219

Local Institution, Lenexa

84124

Local Institution, Salt Lake City

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY